Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Sep;37(9):12387-12396.
doi: 10.1007/s13277-016-5100-4. Epub 2016 Jun 17.

HCV NS4B targets Scribble for proteasome-mediated degradation to facilitate cell transformation

Affiliations

HCV NS4B targets Scribble for proteasome-mediated degradation to facilitate cell transformation

Bo Hu et al. Tumour Biol. 2016 Sep.

Abstract

Hepatitis C virus (HCV) nonstructural protein 4B (NS4B) is a multi-transmembrane protein, but little is known about how NS4B contributes to HCV replication and tumorigenesis. Its C-terminal domain (CTD) has been shown to associate with intracellular membrane, and we have previously shown that NS4B CTD contains a class I PDZ-binding motif (PBM). Here, we demonstrated that NS4B PBM interacts with the PDZ-containing tumor suppressor protein, Scribble, using immunofluorescence and co-immunoprecipitation assays, and this interaction requires at least three contiguous PDZ domains of Scribble. In addition, NS4B PBM specifically induced Scribble degradation by activating the proteasome-ubiquitin pathway. Similar Scribble degradation was also observed in HCV-infected cells, suggesting NS4B could work in the context of HCV. Finally, NS4B PBM mutants showed reduced colony formation capacity compared with its wild-type counterpart, indicating that NS4B PBM plays important roles in NS4B-mediated cell transformation. Altogether, we provide a mechanism by which NS4B induces cell transformation through its PBM, which specifically interacts with the PDZ domains of Scribble and targets Scribble for degradation.

Keywords: HCV; NS4B; PBM; Scribble; Tumorigenesis; Ubiquitin.

PubMed Disclaimer

Conflict of interest statement

None

Figures

Fig. 1
Fig. 1
HCV NS4B co-localized with Scribble protein. Cells were fixed for immunofluorescence analysis at 24 h post-transfection. Cell nuclei were stained by DAPI (in blue). The co-localization between NS4B and Scribble was shown in the merged images (fourth columns)
Fig. 2
Fig. 2
HCV NS4B PBM is required to bind Scribble. Cell extract was incubated with anti-FLAG resin, and the co-immunoprecipitated Scribble was analyzed by Western blot with anti-Scribble antibody
Fig. 3
Fig. 3
Three adjacent PDZ domains of Scribble are required to bind HCV NS4B. a Diagram showing the structure of Scribble protein. The Myc-tagged PDZ domains of Scribble used in the Co-IP assay were indicated, and the binding activities of Scribble PDZ domains for HCV NS4B were summarized. bj 293T cells were transfected with pFLAG-CMV2 or pFLAG-CMV2-NS4B and Myc-tagged Scribble PDZ (b), PDZ1 (c), PDZ2 (d), PDZ3 (e), PDZ4 (f), PDZ1-2 (g), PDZ2-3 (h), PDZ3-4 (i), and PDZ2-4 (j). Cell lysates were mixed with anti-FLAG resin, and the precipitates were analyzed by Western blot with indicated antibodies. k 293T cells were co-transfected with pFLAG-CMV2-NS4B, pCDNA4b, or Myc-tagged Scribble PDZ1-3. Cell lysates were mixed with anti-Myc resin, and the precipitates were analyzed by Western blot with indicated antibodies
Fig. 4
Fig. 4
HCV NS4B induced Scribble degradation. a, b 293T (a) and HepG2 (b) cells were transfected with 1, 3, and 5 μg pCDNA3.1-NS4B expression plasmid. Twenty-four hours post-transfection, cell lysates were prepared and analyzed by Western blot with indicated antibodies. pCDNA3.1(−) plasmid was used as a negative control. c, d 293T (c) and HepG2 (d) cells were transfected with 1 μg of pCDNA3.1-NS4B expression plasmid. Twenty-four and 48 h post-transfection, the protein levels of NS4B, Scribble, and LGL2 were analyzed by Western blot. e, f Relative protein levels of Scribble (e) and LGL2 (f) were quantitated with standard deviation (SD). GAPDH levels were used to normalize these two proteins. *P < 0.05; **P < 0.01
Fig. 5
Fig. 5
HCV NS4B PBM induced Scribble degradation via the proteasome. a 293T and HepG2 cells were transfected with 1 μg pCDNA3.1(−) or pCDNA3.1-NS4B. Twenty-four and 48 h post-transfection, the protein levels of NS4B, USP14, and GAPDH were analyzed by Western blot. b 293T cells and HepG2 cells were transfected with pFLAG-CMV2 or pFLAG-NS4B, and proteasome inhibitor was added to the cells 5 h before harvesting cells. The ubiquitination levels of Scribble were analyzed by Western blot using anti-ubiquitin antibody. c 293T and HepG2 cells were transfected with full-length NS4B, NS4BD, NS4BM, pFLAG-CMV2, and pEFGPC1. Twenty-four hours post-transfection, cell lysates were prepared and analyzed by Western blot with indicated antibodies
Fig. 6
Fig. 6
HCV infection induced Scribble protein degradation. Huh7.5.1 cells were infected by HCV JFH1 and harvested at day 3 and day 5. a Total mRNA was extracted, and RT-PCR was performed using primers for Scribble and β-actin. Data were presented as mean ± SE (n = 3, P>0.05). b Cells lysates were subjected to Western blot analysis using antibodies against HCV Core protein, Scribble, and β-actin
Fig. 7
Fig. 7
NS4B PBM facilitated HepG2 cells transformation. Soft-agar colony formation assay for HepG2 cells transfected with pEGFP-C1 or pEGFP-C1-NS4B or pEGFP-C1-NS4B or pEGFP-C1-NS4BM. Quantification of foci was counted. Values are means ± SD (n = 3). *P < 0.01,**P < 0.05

Similar articles

Cited by

References

    1. Farci P, Shimoda A, Coiana A, et al. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science. 2000;288:339–344. doi: 10.1126/science.288.5464.339. - DOI - PubMed
    1. Halliday J, Klenerman P, Barnes E. Vaccination for hepatitis C virus: closing in on an evasive target. Expert Rev Vaccines. 2011;10:659–672. doi: 10.1586/erv.11.55. - DOI - PMC - PubMed
    1. Scheel TK, Rice CM. Understanding the hepatitis C virus life cycle paves the way for highly effective therapies. Nat Med. 2013;19:837–849. doi: 10.1038/nm.3248. - DOI - PMC - PubMed
    1. Wendt A, Adhoute X, Castellani P, et al. Chronic hepatitis C: future treatment. J Clin Pharmacol. 2014;6:1–17. - PMC - PubMed
    1. Lindenbach BD, Rice CM. Unravelling hepatitis C virus replication from genome to function. Nature. 2005;436:933–938. doi: 10.1038/nature04077. - DOI - PubMed

MeSH terms

LinkOut - more resources